Suppr超能文献

术前预后营养指数可能是肝移植后肝细胞癌复发的有力预测指标。

Preoperative Prognostic Nutritional Index May Be a Strong Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.

作者信息

Kornberg Arno, Kaschny Linda, Kornberg Jennifer, Friess Helmut

机构信息

Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Surgery, Munich, Germany.

出版信息

J Hepatocell Carcinoma. 2022 Jul 27;9:649-660. doi: 10.2147/JHC.S366107. eCollection 2022.

Abstract

PURPOSE

Malnutrition is a major risk factor of immune dysfunction and poor outcome in cancer patients. The prognostic nutritional index (PNI), which is established by serum albumin level and peripheral lymphocyte count, was shown to correlate with prognosis of hepatocellular carcinoma (HCC) patients following liver resection and non-surgical interventions. The aim of this study was to analyze the predictive value of preoperative PNI in liver transplantation (LT) patients with HCC.

PATIENTS AND METHODS

A total of 123 HCC patients that underwent LT were included in the analysis. The prognostic impact of preoperatively assessed clinical factors including the PNI on post-LT outcome was analyzed by uni- and multivariate analysis.

RESULTS

Post-transplant tumor recurrence rates were 5.1% in high-PNI (> 42) and 55.6% in low-PNI (≤ 42) patients ( < 0.001). Preoperative high-PNI could be identified as a significant and independent promoter of both recurrence-free survival (hazard ratio [HR] = 10.12, 95% CI: 3.40-30.10; < 0.001) and overall survival (HR = 1.69, 95% CI: 1.02-2.79; = 0.004) following LT. Apart from that low-PNI proved to be a significant and independent predictor of microvascular tumor invasion (OR = 7.71, 95% CI: 3.17-18.76; < 0.001). In contrast, no tumor morphology features including the Milan criteria revealed an independent prognostic value.

CONCLUSION

Our data indicate that preoperative PNI correlates with biological tumor aggressiveness and outcome following LT in HCC patients and may therefore be useful for refining oncologic risk stratification.

摘要

目的

营养不良是癌症患者免疫功能障碍和预后不良的主要危险因素。由血清白蛋白水平和外周淋巴细胞计数建立的预后营养指数(PNI)已被证明与肝细胞癌(HCC)患者肝切除术后及非手术干预后的预后相关。本研究旨在分析术前PNI对HCC肝移植(LT)患者的预测价值。

患者与方法

共纳入123例行LT的HCC患者进行分析。通过单因素和多因素分析评估术前包括PNI在内的临床因素对LT术后结局的预后影响。

结果

高PNI(>42)患者移植后肿瘤复发率为5.1%,低PNI(≤42)患者为55.6%(<0.001)。术前高PNI可被确定为LT后无复发生存(风险比[HR]=10.12,95%可信区间:3.40-30.10;<0.001)和总生存(HR=1.69,95%可信区间:1.02-2.79;=0.004)的显著且独立的促进因素。除此之外,低PNI被证明是微血管肿瘤侵犯的显著且独立的预测因素(比值比[OR]=7.71,95%可信区间:3.17-18.76;<0.001)。相比之下,包括米兰标准在内的肿瘤形态学特征均未显示出独立的预后价值。

结论

我们的数据表明,术前PNI与HCC患者LT后的肿瘤生物学侵袭性和结局相关,因此可能有助于完善肿瘤学风险分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b32/9342250/c4c84bc5b989/JHC-9-649-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验